As per MarkNtel Advisors the Colorectal Cancer (CRC) Diagnostics and Treatments Market size was valued at around USD10.89 Billion in 2024 and is projected to reach USD16.89 Billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 7.6% during the forecast period, i.e., 2025-30.

Colorectal Cancer (CRC) Diagnostics and Treatments Market Systems Market Analysis :

This market expansion is linked to several factors. The market for colorectal cancer diagnosis and treatment is being greatly boosted by the growth of specialty cancer hospitals around the world. For instance, to enhance local cancer care in Kerala, India opened a six-story cancer specialty block at Ernakulam General Hospital in October 2023. The building has 105 beds contemporary amenities, an intensive care unit, and a chemotherapy unit. To address the growing need for specialized CRC care in the area KLE Society in Belagavi, opened a state-of-the-art 300-bed cancer hospital in December 2024. The facility offers everything from robotic surgery to bone marrow transplants. Herb Chambers donated USD 100 million to Massachusetts General Hospital (USA) in December 2024 so that they could construct a new tower that would allow patients, including those with colorectal cancer to receive more centralized cancer care services.

Explore the Insights – Download a Free Sample: https://www.marknteladvisors.com/query/request-sample/colorectal-cancer-crc-market.html

In case you missed it, we're currently updating our reports. Click below to access a free PDF sample of the latest research, featuring forecasts from 2026 to 2032. The report includes market size, industry trends, and competitive analysis. Our team will promptly deliver the most recent version to you.

Colorectal Cancer (CRC) Diagnostics and Treatments Market Systems Market Segmentation:

  • By Diagnosis
    • Blood & Stool Tests
    • Imaging
    • Biopsy
    • Flexible Sigmoidoscopy
    • Colonoscopy
  • By Treatment
    • Chemotherapy
      • Alkylating Agents
      • Antimetabolites
        • Fluorouracil
        • Capecitabine
      • Others
    • Immunotherapy
      • Monoclonal Antibodies
        • Bevacizumab
        • Cetuximab
        • Panitumumab
      • Biologic Response Modifiers
      • Colony-Stimulating Factors
      • Tumor Vaccines
    • Surgery
    • Targeted Therapy
    • Others (Radiofrequency Ablation (RFA), etc.)
  • By End-User
    • Hospitals
    • Specialty Clinics
    • Others (Ambulatory Surgery Centers, etc.)
  • By Region
    • North America
    • South America
    • Europe
    • Middle East & Africa
    • Asia-Pacific

Colorectal Cancer (CRC) Diagnostics and Treatments Market Recent Development:

January 2025: Amgen Inc. got approval from the FDA to expand the label of its KRAS inhibitor Lumakras (sotorasib), opening up its use in colorectal cancer. With this, Lumakras can now be combined with another Amgen asset, the antibody Vectibix (panitumumab), to treat adult patients with metastatic disease who are carrying the G12C KRAS mutation.

Report Delivery Format – Market research reports from MarkNtel Advisors are delivered in PDF, Excel, and PowerPoint formats. Once the payment is successfully processed, the report will be sent to your registered email within 24 hours.

Colorectal Cancer (CRC) Diagnostics and Treatments Market Drivers:

High Ubiquity of Colorectal Cancer Driving Demand – Globally, colorectal cancer is a major health concern. 930,000 people died and 10. 9 million new cases were reported worldwide in 2020. The number of cases is expected to increase to 32. 2 million by 2040, with 12. 6 million expected deaths. The disease is most common in countries with high or extremely high HDI. With 10% of cases worldwide, it is the second most common cause of cancer-related deaths and the third most common type of cancer overall. Different geographic prevalence rates indicate that colorectal cancer (CRC) is most common in Australia, New Zealand, and Europe, while it is less common in some parts of Africa and Southern Asia.

Report Highlights Essential Insights for Strategic Decision-Making

  • Detailed market size, share, and forecast analysis
    • In-depth pricing trends and segment-wise cost evaluations
    • Key industry strategies, including innovation, partnerships, and acquisitions
    • Critical value chain analysis and stakeholder profiling
    • Regional import-export market insights and trade flow assessment
    • Thorough competitive benchmarking of top hearing aid manufacturers
    • Identification of new growth opportunities and niche market segments
    • Overview of market trends, drivers, and challenges shaping future demand

Some of the leading players in the Colorectal Cancer (CRC) Diagnostics and Treatments Market are:

  • Abbott Laboratories
  • Amgen Inc.
  • Bayer AG
  • Bristol Myers Squibb
  • Eli Lilly and Company
  • GlaxoSmithKline PLC
  • Hoffmann-La Roche AG
  • Merck & Co., Inc.
  • Novartis International AG
  • Pfizer Inc.
  • Others

Gain exclusive access to our comprehensive insights on the Future of Russia Forage Seed Market. With tailored licensing options, including Mini Report Pack, Excel Data Pack, Single User, Multiuser, and Enterprise Packs, our research empowers organizations to navigate dynamic market trends effectively.

Select a License That Matches Your Business Requirements with Instant Offer- https://www.marknteladvisors.com/pricing/colorectal-cancer-crc-market.html

Research Methodology Summary

A systematic approach is used to ensure accurate market insights, combining both bottom-up and top-down methods. Data triangulation validates findings from multiple angles.

Key Steps:

  • Define objectives and research design
  • Collect data through surveys and interviews
  • Analyze and validate data using reliable tools
  • Forecast trends and deliver actionable insights

Other Report-

India Data Center Market to Grow at 14.60% During 2026-32, Driven by AI Integration, Hyperscale Expansion, and Digital Infrastructure Investments - MarkNtel Advisors

About us:

MarkNtel Advisors is a globally recognized market research and consulting firm delivering intelligence across the healthcare industry, spanning pharmaceuticals, medical devices, healthcare IT, and biotechnology. Our analysts combine domain expertise with innovation tracking to help healthcare organizations improve efficiency and patient outcomes. Through Consulting Services, we assist clients in interpreting insights, designing go-to-market strategies, and adapting to regulatory changes, fostering sustainable growth in the evolving global healthcare ecosystem.

Reach Us:

MarkNtel Advisors

Sector 63, Noida, Uttar Pradesh-201301, India

Contact No: +91 8719999009

Email: sales@marknteladvisors.com

Visit our Website: https://www.marknteladvisors.com